Lexology January 8, 2026
Michael Best & Friedrich LLP

Amanda Wait, Partner and Antitrust & Competition Leader, and Katelyn Pellitteri, Partner, authored an article for Law360, now available in full on our website.

In 2025, healthcare companies navigated a rapidly evolving landscape shaped by the passage of the One Big Beautiful Bill Act and substantial modifications to healthcare funding models.

These legislative and regulatory changes required businesses to reassess their operations, compliance strategies and reimbursement models to remain competitive and compliant.

Against this backdrop, the healthcare industry braced for significant antitrust enforcement shifts, driven by a change in presidential administration and new leadership at both the Federal Trade Commission and the U.S. Department of Justice’s Antitrust Division.

These agencies initiated new enforcement actions, faced complex decisions regarding ongoing inherited...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies
Federal Discretionary Spending To Address Substance Use Disorders: How Big A Shift?
White House and Congress Turn Focus to Health Policy
CVS accused of shutting out rival pharmacy hubs in House Judiciary investigation
OIG Recounts Historic Recovery Numbers in Its Latest Semiannual Report to Congress
What is included in Trump’s “Great Healthcare Plan”?

Share Article